Sanofi - Consensus Indicates Potential 30.1% Upside - Direct

Sanofi - Consensus Indicates Potential 30.1% Upside

Related Keywords

France , United States , Paris , France General , , Scribe Therapeutics Inc , Amunix Pharmaceuticals Inc , Provention Bio Inc , Skyhawk Therapeutics Inc , Bio Inc , Seagen Inc , Blackstone Life Sciences , Biosciences Inc , Consumer Healthcare , Skyhawk Therapeutics , Amunix Pharmaceuticals , Scribe Therapeutics , Provention Bio ,